Get started
RocketTickers

RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 St

Long
Redhill Biopharma Ltd. (NASDAQ:RDHL)  
RocketTickers  
NASDAQ:RDHL   Redhill Biopharma Ltd.
Beyond Technical Analysis
2
0
beyondta
RDHL: RedHill Biopharma Ltd.
2020-07-31 07:00:10
RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 Study with RHB-204 for NTM Infections
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.